Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse
- 30 July 2019
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 178 (1) , 63-73
Abstract
Background Chromosomal instabilities (CIN) of plasma cell-free DNA (cfDNA) are common in breast cancer. We aimed to investigate the value of cfDNA CIN in monitoring the breast cancer relapse and additionally to compare it with the traditional biomarkers (CA15-3 and CEA). Methods Overall 62 recurrent breast cancer patients and 20 healthy controls were recruited. Low-pass whole-genome sequencing (LPWGS) was performed to detect cfDNA CIN. A CIN score was calculated. The performance of CA15-3, CEA, and CIN score in monitoring the recurrence was investigated with receiver operating characteristic (ROC) curve and the area under curve (AUC). Multivariable Cox proportional hazard model was established to analyze the correlations between copy number gain/loss and disease-free survival (DFS). Results cfDNA CIN achieved the positive rate of 77.6% [(95% confidence interval (CI) 73.4–95.3%)] among recurrent breast cancer patients, with an AUC value of 0.933, superior to CA15-3 (positive rate: 38.7%; AUC: 0.864) and CEA (positive rate: 41.93%; AUC: 0.878) (P < 0.01). The combination of cfDNA CIN with two biomarkers further increased the positive rate to 88.7% (95% confidence interval 77.5–95.0%). cfDNA CIN achieved better performance in patients with shorter DFS (≤ 41 months), with an AUC value of 0.975. Conclusions cfDNA CIN yields a higher accuracy in monitoring breast cancer recurrence compared to traditional biomarkers (CA15-3 and CEA), especially for biomarker-negative patients. The combination of cfDNA CIN to traditional biomarkers further improved the detection rate of recurrence, which may provide a new method for monitoring the early relapse of breast cancer, though further investigations are warranted.Keywords
Funding Information
- National Natural Science Foundation of China (81672597)
- Natural Science Foundation of Zhejiang Province, China (LY17H160038)
- Key Research-Development Program of Zhejiang Province (2019C04001, 2017C03013)
- Zhejiang Provincial Key Laboratory of Wood Science and Technology (2017RC014, WKJ-ZJ-1714)
- Zhejiang Province Public Welfare Technology Application Research Project (QJD1602026)
- Natural Science Foundation of Zhejiang Province (LY14H160030)
This publication has 29 references indexed in Scilit:
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageNature Medicine, 2014
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancerNature Genetics, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Prognostic role of CA15.3 in 7942 patients with operable breast cancerBreast Cancer Research and Treatment, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypesBreast Cancer Research and Treatment, 2010
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerCancer Research, 2010
- Integrative Genomic Approaches Identify IKBKE as a Breast Cancer OncogeneCell, 2007
- False Elevation of Serum CA 15-3 Levels in Patients Under Follow-Up for Breast CancerThe Breast Journal, 2004